315 Frequency and acceptance of CDSS-generated STOPP/START signals - SI Table SI1.2. Continued START criteria (n=31) All countries Belgium (BE) Switzerland (CH) Ireland (IE) The Netherlands (NL) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) E 5. Vitamin D supplement in older people who are housebound or experiencing falls or with osteopenia (Bone Mineral Density T-score is > -1.0 but < -2.5 in multiple sites). 99 75.8% 4 50.0% 46 76.1% 13 61.5% 36 83.3% A 5. Statin therapy with a documented history of coronary, cerebral or peripheral vascular disease, unless the patient’s status is end-oflife or age is > 85 years. 80 62.5% 10 80.0% 38 50.0% 5 60.0% 27 74.1% G 2. 5-alpha reductase inhibitor with symptomatic prostatism, where prostatectomy is not considered necessary. 79 15.2% 16 31.3% 46 13.0% 1 0.0% 16 6.3% D 2. Fibre supplements (e.g. bran, ispaghula, methylcellulose, sterculia) for diverticulosis with a history of constipation. 76 18.4% 6 16.7% 38 0% 15 73.3% 17 11.8% A 1/A 2. Start vitamin K antagonists or direct thrombin inhibitors or factor Xa inhibitors in the presence of chronic atrial fibrillation. If oral anticoagulants are contra-indicated, start aspirin instead. 72 50.0% 17 17.6% 31 58.1% 12 83.3% 12 41.7% A 7. Beta-blocker with ischaemic heart disease. 69 34.8% 4 75.0% 35 31.4% 6 66.7% 24 25.0% 4
RkJQdWJsaXNoZXIy MTk4NDMw